Corwin A Robertson
Overview
Explore the profile of Corwin A Robertson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
306
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Robertson C, Tsang P, Landolfi V, Greenberg D
Expert Rev Vaccines
. 2016 Jul;
15(10):1245-53.
PMID: 27457797
Introduction: An intradermal version of Fluzone® split-virion inactivated trivalent influenza vaccine, containing 9 µg hemagglutinin per strain of A/H1N1, A/H3N2, and one B lineage virus (Fluzone Intradermal, Sanofi Pasteur), became...
12.
DiazGranados C, Dunning A, Robertson C, Talbot H, Landolfi V, Greenberg D
Clin Infect Dis
. 2016 Feb;
62(9):1092-1099.
PMID: 26908801
Background: High-dose inactivated influenza vaccine (IIV-HD) is an alternative to the standard-dose inactivated influenza vaccine (IIV-SD) in the United States for influenza prevention in older adults. IIV-HD improved efficacy relative...
13.
DiazGranados C, Robertson C, Talbot H, Landolfi V, Dunning A, Greenberg D
Vaccine
. 2015 Jul;
33(38):4988-93.
PMID: 26212007
Background: A recent study showed that a high-dose inactivated influenza vaccine (IIV-HD) was 24.2% more efficacious than a standard-dose inactivated influenza vaccine (IIV-SD) in preventing laboratory-confirmed symptomatic influenza in adults...
14.
DiazGranados C, Dunning A, Robertson C, Talbot H, Landolfi V, Greenberg D
Vaccine
. 2015 Jul;
33(36):4565-71.
PMID: 26187260
Background: A randomized trial demonstrated that a high-dose inactivated influenza vaccine (IIV-HD) was 24.2% more efficacious than a standard-dose vaccine (IIV-SD) against laboratory-confirmed influenza illness in adults ≥65 years. To...
15.
Decker M, DiazGranados C, Chit A, Hosbach P, Robertson C, Greenberg D
Clin Infect Dis
. 2015 Jul;
61(8):1344-5.
PMID: 26157048
No abstract available.
16.
Greenberg D, Robertson C, Landolfi V, Bhaumik A, Senders S, Decker M
Pediatr Infect Dis J
. 2014 Jan;
33(6):630-6.
PMID: 24445833
Background: Strains of 2 distinct influenza B lineages (Victoria and Yamagata) have cocirculated in the United States for over a decade, but trivalent influenza vaccines (TIVs) contain only 1 B-lineage...
17.
Greenberg D, Robertson C, Gordon D
Pediatr Ann
. 2013 Aug;
42(8):172-7.
PMID: 23910031
Influenza and dengue are viral illnesses of global public health importance, especially among children. Accordingly, these diseases have been the focus of efforts to improve their prevention and control. Influenza...
18.
Robertson C
S D Med
. 2013 Mar;
Spec no:38-45.
PMID: 23444590
Vaccination remains a critically important public health tool. It has been responsible for drastically reducing the occurrence of diseases that were once responsible for invoking extreme fear and anxiety. As...
19.
Greenberg D, Robertson C, Noss M, Blatter M, Biedenbender R, Decker M
Vaccine
. 2012 Dec;
31(5):770-6.
PMID: 23228813
Purpose: To evaluate the safety and immunogenicity of a prototype quadrivalent inactivated influenza vaccine (QIV) containing two influenza B strains, one of each lineage, compared with licensed trivalent inactivated influenza...
20.
Tan E, Robertson C, Brynildsen S, Bresnitz E, Tan C, McDonald C
Emerg Infect Dis
. 2007 Jun;
13(3):498-500.
PMID: 17552112
Recent emergence of a virulent strain of Clostridium difficile demonstrates the importance of tracking C. difficile incidence locally. Our survey of New Jersey hospitals documented increases in the rates of...